Stereotactic body radiotherapy as a boost after external beam radiotherapy for high-risk prostate cancer patients.

Turna, Menekse; Akboru, Halil; Ermis, Ekin; Oskeroglu, Sedenay; Dincer, Selvi; Altin, Suleyman

Turna, Menekse; Akboru, Halil; Ermis, Ekin; Oskeroglu, Sedenay; Dincer, Selvi; Altin, Suleyman.

Affiliation

Turna M; Radiation Oncology Department, Okmeydani Research and Education Hospital, Sisli, Istanbul, Turkey.
Akboru H; Radiation Oncology Department, Okmeydani Research and Education Hospital, Sisli, Istanbul, Turkey.
Ermis E; Radiation Oncology Department, Okmeydani Research and Education Hospital, Sisli, Istanbul, Turkey.
Oskeroglu S; Radiation Oncology Department, Okmeydani Research and Education Hospital, Sisli, Istanbul, Turkey.
Dincer S; Radiation Oncology Department, Okmeydani Research and Education Hospital, Sisli, Istanbul, Turkey.
Altin S; Radiation Oncology Department, Okmeydani Research and Education Hospital, Sisli, Istanbul, Turkey.

Indian J Cancer ; 58(4): 518-524, 2021.

Article in En | MEDLINE | ID: mdl-33402584

Subject(s)

Brachytherapy/methods; Prostatic Neoplasms/radiotherapy; Quality of Life/psychology; Radiosurgery/methods; Female; Humans; Male; Risk Factors

Key words

Intensity modulated radiation therapy; prostate cancer; quality of life; stereotactic body radiotherapy; toxicity

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Quality of Life / Brachytherapy / Radiosurgery Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Aspects: Patient_preference Limits: Female / Humans / Male Language: En Journal: Indian J Cancer Year: 2021 Document type: Article Affiliation country: Turkey Country of publication: India

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google